To explore the demographics of AAMDC expression, we performed immunohistochemistry (IHC, Fig. 1c) in a breast tissue microarray (Biomax) including normal breast tissue, benign breast lesions, and 60 high-risk BC cases (Supplementary Fig. 1a and b for validation of the α-AAMDC antibody). This evidence concerns the gene AAMDC and breast cancer.